ESTRO 2024 - Abstract Book

S564

Clinical - Breast

ESTRO 2024

DIBH technique contributes to reduce doses to the heart, coronary arteries and ipsilateral lung in radiotherapy treatments in left-sided breast cancer. Patients with a high life expectancy or who have some cardiac pathology would benefit the most from DIBH technique.

Keywords: Breast cancer, DIBH, doses

References:

1.Risk of ischemic heart disease in women after radiotherapy for breast cancer. S.C. Darby , M. Ewertz et al. N Engl J Med (11) 2013 987-998.

2.(Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility. S. Gaál, Z. Kahán et al. Radiation Oncology 16 (89) (2021)

3.Dosimetric analysis of Deep Inspiratory Breath-hold technique (DIBH) in left-sided breast cancer radiotherapy and evaluation of pre- treatment predictors of cardiac doses for guiding patient selection for DIBH. S. Ferdinand, M. Mondal et al. Technical Innovations & Patient Support in Radiation Oncology 17 (2021) 25-31

1587

Digital Poster

Breast cancer annotation across genders

Madalina-Liana Costea 1 , Lorenzo Colombo 1 , Gorkem Gungor 2 , Guillaume Klausner 3,4 , Jean-Baptiste Clavier 5 , Nicolas Leduc 6 , Celine Bourgier 7 , Charlotte Robert 8 , Chloe Herve 9 , Enis Ozyar 2 , Sami Romdhani 10 , Olivier Teboul 10 , Gizem Temiz 1 , Nikos Paragios 11 1 TheraPanacea, Clinical Affairs, Paris, France. 2 Acibadem MAA University School of Medicine, Department of Radiation Oncology, Istanbul, Turkey. 3 Centre de Haute Énergie (C.H.E.) Nice - Bastia, Department of Radiation Oncology, Bastia, France. 4 Hôpitaux Universitaires de Genève, Department of Radiation Oncology, Geneva, Swaziland. 5 ICANS - Institut de cancérologie Strasbourg Europe, Department of Radiation Oncology, Strasbourg, France. 6 Centre Catalan d'Oncologie, Department of Radiation Oncology, Perpignan, France. 7 Institut du Cancer de Montpellier, Department of Radiation Oncology, Montpellier, France. 8 Institut Gustave Roussy, Department of Radiation Oncology, Villejuif, France. 9 Centre Hospitalier Départemental Vendée, Department of radiation oncology, La Roche-sur-Yon, France. 10 TheraPanacea, AI engineering, Paris, France. 11 TheraPanacea, CEO, Paris, France

Purpose/Objective:

Male breast cancer is a rare disease that affects 1% of male population with a peak distribution at the age of 71 [1]. AI-based segmentation models can provide precise contours for accurately targeting tumors while sparing healthy tissues and reduce manual contouring time in radiotherapy (RT) treatment planning. However due to high cancer